Literature DB >> 30640282

OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.

Fusheng Tang1, Xiuhong Qin, Jianmin Lu, Peng Song, Mingshu Li, Xiang Ma.   

Abstract

PURPOSE: To identify the spectral domain optical coherence tomography predictors of visual prognosis in retinal vein occlusion macular edema after intravitreal conbercept injection.
METHODS: Retrospective cohort study of 63 treatment-naive retinal vein occlusion macular edema eyes received pro re nata intravitreal conbercept with at least 3 months of follow-up. The best-corrected visual acuity (BCVA) and optical coherence tomography scans were recorded at baseline, 1 month, and 3 months after starting therapy. On spectral domain optical coherence tomography, the following lesions in the 1-mm-wide retinal area centered on the fovea: disorganization of the retinal inner layer extent, cysts, hyperreflective foci, microaneurysms, external limiting membrane or ellipsoid zone disruption, foveal bulge, and foveal depression were evaluated by masked graders. Regression analysis was used to determine independent predictors of BCVA at 1- and 3-month follow-up.
RESULTS: The thicker central subfield thickness, greater extent of external limiting membrane disruption, and presence of hyperreflective foci >20 at baseline were correlated with the worse baseline BCVA (all P < 0.05). The greater extent of external limiting membrane disruption and presence of hyperreflective foci >20 at baseline were associated with poorer BCVA during follow-up (all P < 0.05). The central subfield thickness and extent of ellipsoid zone disruption at baseline and their changes over time were correlated with the 3-month BCVA improvement (all P < 0.05). Furthermore, changes in the ellipsoid zone disruption extent or central subfield thickness after 1 month identified eyes with a high likelihood of subsequent BCVA improvement or decline.
CONCLUSION: The external limiting membrane status and hyperreflective foci >20 at baseline could be good predictors for short-term visual outcome, whereas the central subfield thickness and ellipsoid zone status at baseline and their changes over time may predict visual improvement in patients with retinal vein occlusion macular edema after intravitreal conbercept injection.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30640282     DOI: 10.1097/IAE.0000000000002444

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  13 in total

1.  Comment on "Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography".

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

2.  Efficacy of intravitreal conbercept injection on short- and long-term macular edema in branch retinal vein occlusion.

Authors:  Jing-Yi Bai; Wen-Ying Wang; Zhi-Zhi Dou; Bo-Chao Geng; Xiao-Yan Xu; Yuan-Zhang Zhu; Shan-Yao Zhao; Min Liu; Shao-You Jia; Wen-Juan Luo
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

Review 3.  [Biomarkers in the treatment of retinal vein occlusion].

Authors:  Jakob Siedlecki; Lars-Olof Hattenbach; Nikolas Feltgen; Siegfried G Priglinger
Journal:  Ophthalmologie       Date:  2022-10-06

Review 4.  Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.

Authors:  Alicia J Jenkins; Maria B Grant; Julia V Busik
Journal:  Diabetologia       Date:  2022-02-11       Impact factor: 10.460

5.  Association of retinal biomarkers and choroidal vascularity index on optical coherence tomography using binarization method in retinitis pigmentosa.

Authors:  Ebru N Cetin; Osman Parca; Hasan Samed Akkaya; Gökhan Pekel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-12       Impact factor: 3.117

6.  Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.

Authors:  Wenqi Song; Wanzhen Jiao; Fengjiao Li; Aihua Ma; Bojun Zhao
Journal:  Biomed Res Int       Date:  2020-06-19       Impact factor: 3.411

7.  A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study.

Authors:  Tyler Etheridge; Ellen T A Dobson; Marcel Wiedenmann; Chandana Papudesu; Ingrid U Scott; Michael S Ip; Kevin W Eliceiri; Barbara A Blodi; Amitha Domalpally
Journal:  PLoS One       Date:  2020-04-30       Impact factor: 3.240

8.  Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.

Authors:  Tyler Etheridge; Ellen T A Dobson; Marcel Wiedenmann; Neal Oden; Paul VanVeldhuisen; Ingrid U Scott; Michael S Ip; Kevin W Eliceiri; Barbara A Blodi; Amitha Domalpally
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.283

9.  A retrospective study assessing the factors associated with visual outcome in retinal vein occlusion patients after anti-VEGF therapy.

Authors:  Xiaoran Liu; Chi Xie; Yun Wang; Yue Xu; Shaojin Zhu; Yan Fang
Journal:  PeerJ       Date:  2021-12-06       Impact factor: 2.984

10.  Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.

Authors:  Bing Li; Meng-Da Li; Jun-Jie Ye; Zhe Chen; Zi-Jian Guo; Yu Di
Journal:  Chin Med J (Engl)       Date:  2020-03-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.